Land Transfer Plan between AiBtl BioPharma Inc. and YunZhiYi Co., Ltd. (March 31, 2025)
AiBtl BioPharma Inc. outlines its plan to transfer ownership of five parcels of land in Taiwan, currently held by three Taiwanese nationals due to local legal restrictions, to its Taiwan subsidiary, YunZhiYi Co., Ltd. The transfer process, managed by a registered land agent, is under government review and expected to complete by the end of 2025. Until then, AiBtl BioPharma Inc. will retain control through contractual agreements and will update its financial disclosures accordingly.
Exhibit 10.56
AiBtl BioPharma Inc.
Company Land Transfer Plan
Background
In response to Taiwan’s legal restrictions prohibiting foreign legal entities from directly registering farmland ownership, AiBtl BioPharma Inc. appointed three Taiwanese nationals — Ting, Huei-Hua, Fang, Ya-Rong, and Fang, Hsi-Chuan — to hold legal title to the land. The Company entered into a Nominee Holding Agreement and Lease Agreement to ensure effective control and economic interest.
Transfer Plan
In 2024, the Company engaged a registered land agent to initiate the title transfer of the five parcels to Taiwan subsidiary, YunZhiYi Co., Ltd.
The transfer is currently under government review, pending completion of the title transfer registration.
Timeline for Completion
The Company targets to complete the title transfer by the end of 2025, subject to the timeline and outcome of regulatory reviews.
Risk Management and Financial Disclosure
Until the legal transfer is finalized, the Company will maintain effective control through valid contractual arrangements and will disclose the status of land control and transfer progress in its financial statements.
AiBtl BioPharma Inc.
Name: Russman Jaimes
Title: CEO
Date: 2025/03/31
